New York, NY, United States of America

Yitshak Francis

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Yitshak Francis: Innovator in Neurodegenerative Disorder Treatments

Introduction

Yitshak Francis is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of neurodegenerative disorders. With a total of four patents to his name, Francis is recognized for his innovative approaches to complex health issues.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Histone acetyltransferase activators and uses thereof." This invention provides a method for screening compounds that bind to and modulate a histone acetyltransferase protein. Furthermore, it outlines methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein, as well as cancer, by administering a HAT-activating compound to a subject.

Career Highlights

Yitshak Francis is affiliated with Columbia University, where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize treatment options for various neurodegenerative conditions.

Collaborations

Some of his notable coworkers include Mauro Fa and Ottavio Arancio, who contribute to the collaborative efforts in research and development within the institution.

Conclusion

Yitshak Francis stands out as an influential inventor in the realm of medical research, particularly for his work on histone acetyltransferase activators. His contributions have the potential to significantly impact the treatment of neurodegenerative disorders and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…